|
PITPNB expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.53369983380003E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.63082913629387E-12 |
| Normal-vs-Stage2 |
3.780800E-03 |
| Normal-vs-Stage3 |
3.65979999999988E-05 |
| Normal-vs-Stage4 |
4.42560000000203E-05 |
| Stage1-vs-Stage2 |
9.020500E-02 |
| Stage1-vs-Stage3 |
4.174300E-02 |
| Stage1-vs-Stage4 |
8.799900E-02 |
| Stage2-vs-Stage3 |
8.799200E-01 |
| Stage2-vs-Stage4 |
8.114200E-01 |
| Stage3-vs-Stage4 |
9.120400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.02610031582628E-10 |
| Normal-vs-AfricanAmerican |
2.556500E-03 |
| Normal-vs-Asian |
7.818400E-03 |
| Caucasian-vs-AfricanAmerican |
1.659970E-01 |
| Caucasian-vs-Asian |
8.565600E-01 |
| AfricanAmerican-vs-Asian |
4.584800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.66900000486692E-08 |
| Normal-vs-Female |
3.19929638337157E-11 |
| Male-vs-Female |
2.844100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.778780E-03 |
| Normal-vs-Age(41-60Yrs) |
1.25230048553249E-10 |
| Normal-vs-Age(61-80Yrs) |
1.25869999978434E-08 |
| Normal-vs-Age(81-100Yrs) |
8.864300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.150200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.710000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.825400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.962410E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.104800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.147800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.41580000004404E-06 |
| Normal-vs-Grade 2 |
8.08575428834502E-13 |
| Normal-vs-Grade 3 |
1.96476999999584E-05 |
| Normal-vs-Grade 4 |
4.221900E-04 |
| Grade 1-vs-Grade 2 |
4.632600E-01 |
| Grade 1-vs-Grade 3 |
2.222000E-02 |
| Grade 1-vs-Grade 4 |
7.125800E-02 |
| Grade 2-vs-Grade 3 |
9.63349999999474E-05 |
| Grade 2-vs-Grade 4 |
1.741780E-02 |
| Grade 3-vs-Grade 4 |
8.253200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.14575016141316E-13 |
| Normal-vs-ccB subtype |
4.30750000002256E-07 |
| ccA subtype-vs-ccB subtype |
6.696300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.42390038332985E-10 |
| Normal-vs-N1 |
2.406400E-02 |
| N0-vs-N1 |
4.165800E-01 |
|
|
